Effects of Smoking on SARS-CoV-2 Positivity: A Study of in Northern and Central California

Introduction COVID-19 continues to impact vulnerable populations disproportionally. Identifying modifiable risk factors could lead to targeted interventions to reduce infections. The purpose of this study is to identify risk factors for testing positive for SARS-CoV-2. Methods Using electronic healt...

Full description

Bibliographic Details
Main Authors: Jiang Li, Meghan C Martinez, Dominick L Frosch, Georg E Matt
Format: Article
Language:English
Published: SAGE Publishing 2022-07-01
Series:Tobacco Use Insights
Online Access:https://doi.org/10.1177/1179173X221114799
_version_ 1811322435338764288
author Jiang Li
Meghan C Martinez
Dominick L Frosch
Georg E Matt
author_facet Jiang Li
Meghan C Martinez
Dominick L Frosch
Georg E Matt
author_sort Jiang Li
collection DOAJ
description Introduction COVID-19 continues to impact vulnerable populations disproportionally. Identifying modifiable risk factors could lead to targeted interventions to reduce infections. The purpose of this study is to identify risk factors for testing positive for SARS-CoV-2. Methods Using electronic health records collected from a large ambulatory care system in northern and central California, the study identified patients who had a test for SARS-CoV-2 between 2/20/2020 and 3/31/2021. The adjusted effect of active and passive smoking and other risk factors on the probability of testing positive for SARS-CoV-2 were estimated using multivariable logistic regression. Analyses were conducted in 2021. Results Of 556 690 eligible patients in our sample, 70 564 (12.7%) patients tested positive for SARS-CoV-2. Younger age, being male, racial/ethnic minorities, and having mild major comorbidities were significantly associated with a positive SARS-CoV-2 test. Current smokers (adjusted OR: 0.69, 95% CI: 0.66-0.73) and former smokers (adjusted OR: 0.92, 95% CI: 0.89-0.95) were less likely than nonsmokers to be lab-confirmed positive, but no statistically significant differences were found when comparing passive smokers with non-smokers. The patients with missing smoking status (25.7%) were more likely to be members of vulnerable populations with major comorbidities (adjusted OR ranges from severe: 2.52, 95% CI = 2.36-2.69 to mild: 3.28, 95% CI = 3.09-3.48), lower income (adjusted OR: 0.85, 95% CI: 0.85-0.86), aged 80 years or older (adjusted OR: 1.11, 95% CI: 1.07-1.16), have less access to primary care (adjusted OR: 0.07, 95% CI: 0.07-0.07), and identify as racial ethnic minorities (adjusted OR ranges from Hispanic: 1.61, 95% CI = 1.56-1.65 to Non-Hispanic Black: 2.60, 95% CI = 2.5-2.69). Conclusions Our findings suggest that the odds of testing positive for SARS-CoV-2 were significantly lower in smokers compared to nonsmokers. Other risk factors include missing data on smoking status, being under 18, being male, being a racial/ethnic minority, and having mild major comorbidities. Since those with missing data on smoking status were more likely to be members of vulnerable populations with higher smoking rates, the risk of testing positive for SARS-CoV-2 among smokers may have been underestimated due to missing data on smoking status. Future studies should investigate the risk of severe outcomes among active and passive smokers, the role that exposure to tobacco smoke constitutes among nonsmokers, the role of comorbidities in COVID-19 disease course, and health disparities experienced by disadvantaged groups.
first_indexed 2024-04-13T13:35:02Z
format Article
id doaj.art-c1ae5dce9d334ae084df98dc99e7018b
institution Directory Open Access Journal
issn 1179-173X
language English
last_indexed 2024-04-13T13:35:02Z
publishDate 2022-07-01
publisher SAGE Publishing
record_format Article
series Tobacco Use Insights
spelling doaj.art-c1ae5dce9d334ae084df98dc99e7018b2022-12-22T02:44:48ZengSAGE PublishingTobacco Use Insights1179-173X2022-07-011510.1177/1179173X221114799Effects of Smoking on SARS-CoV-2 Positivity: A Study of in Northern and Central CaliforniaJiang LiMeghan C MartinezDominick L FroschGeorg E MattIntroduction COVID-19 continues to impact vulnerable populations disproportionally. Identifying modifiable risk factors could lead to targeted interventions to reduce infections. The purpose of this study is to identify risk factors for testing positive for SARS-CoV-2. Methods Using electronic health records collected from a large ambulatory care system in northern and central California, the study identified patients who had a test for SARS-CoV-2 between 2/20/2020 and 3/31/2021. The adjusted effect of active and passive smoking and other risk factors on the probability of testing positive for SARS-CoV-2 were estimated using multivariable logistic regression. Analyses were conducted in 2021. Results Of 556 690 eligible patients in our sample, 70 564 (12.7%) patients tested positive for SARS-CoV-2. Younger age, being male, racial/ethnic minorities, and having mild major comorbidities were significantly associated with a positive SARS-CoV-2 test. Current smokers (adjusted OR: 0.69, 95% CI: 0.66-0.73) and former smokers (adjusted OR: 0.92, 95% CI: 0.89-0.95) were less likely than nonsmokers to be lab-confirmed positive, but no statistically significant differences were found when comparing passive smokers with non-smokers. The patients with missing smoking status (25.7%) were more likely to be members of vulnerable populations with major comorbidities (adjusted OR ranges from severe: 2.52, 95% CI = 2.36-2.69 to mild: 3.28, 95% CI = 3.09-3.48), lower income (adjusted OR: 0.85, 95% CI: 0.85-0.86), aged 80 years or older (adjusted OR: 1.11, 95% CI: 1.07-1.16), have less access to primary care (adjusted OR: 0.07, 95% CI: 0.07-0.07), and identify as racial ethnic minorities (adjusted OR ranges from Hispanic: 1.61, 95% CI = 1.56-1.65 to Non-Hispanic Black: 2.60, 95% CI = 2.5-2.69). Conclusions Our findings suggest that the odds of testing positive for SARS-CoV-2 were significantly lower in smokers compared to nonsmokers. Other risk factors include missing data on smoking status, being under 18, being male, being a racial/ethnic minority, and having mild major comorbidities. Since those with missing data on smoking status were more likely to be members of vulnerable populations with higher smoking rates, the risk of testing positive for SARS-CoV-2 among smokers may have been underestimated due to missing data on smoking status. Future studies should investigate the risk of severe outcomes among active and passive smokers, the role that exposure to tobacco smoke constitutes among nonsmokers, the role of comorbidities in COVID-19 disease course, and health disparities experienced by disadvantaged groups.https://doi.org/10.1177/1179173X221114799
spellingShingle Jiang Li
Meghan C Martinez
Dominick L Frosch
Georg E Matt
Effects of Smoking on SARS-CoV-2 Positivity: A Study of in Northern and Central California
Tobacco Use Insights
title Effects of Smoking on SARS-CoV-2 Positivity: A Study of in Northern and Central California
title_full Effects of Smoking on SARS-CoV-2 Positivity: A Study of in Northern and Central California
title_fullStr Effects of Smoking on SARS-CoV-2 Positivity: A Study of in Northern and Central California
title_full_unstemmed Effects of Smoking on SARS-CoV-2 Positivity: A Study of in Northern and Central California
title_short Effects of Smoking on SARS-CoV-2 Positivity: A Study of in Northern and Central California
title_sort effects of smoking on sars cov 2 positivity a study of in northern and central california
url https://doi.org/10.1177/1179173X221114799
work_keys_str_mv AT jiangli effectsofsmokingonsarscov2positivityastudyofinnorthernandcentralcalifornia
AT meghancmartinez effectsofsmokingonsarscov2positivityastudyofinnorthernandcentralcalifornia
AT dominicklfrosch effectsofsmokingonsarscov2positivityastudyofinnorthernandcentralcalifornia
AT georgematt effectsofsmokingonsarscov2positivityastudyofinnorthernandcentralcalifornia